PharmaBioSource provided exclusive consulting services to Indivior on its acquisition of Sagent Pharmaceutical’s sterile fill / finish manufacturing facility in Raleigh, North Carolina.
- Service: Consulting
- Sector: Pharmaceuticals
- Sub-sector: Sterile Injectables Manufacturing
- Engagement Type: Buy Side
The Raleigh facility includes 80,000 SF of sterile drug product manufacturing, quality control laboratories, offices and GMP warehouse spaces. Indivior plans to utilize the facility for the manufacture of its opioid use disorder (OUD) treatment, SUBLOCADE. PharmaBioSource’s services included target identification, buy-side data room review, due diligence and negotiations support.
Press Release
